VanEck Biotech ETF (BBH)
NASDAQ: BBH
· Real-Time Price · USD
148.53
0.19 (0.13%)
At close: Jun 02, 2025, 10:12 AM
0.13% (1D)
| Bid | 148.24 |
| Market Cap | 349.8M |
| AUM | 329.18M |
| NAV | 148.51 |
| EPS (ttm) | 5.96 |
| PE Ratio (ttm) | 24.90 |
| Shares Out | 2.36M |
| Inception Date | Dec 19, 2011 |
| Ask | 149.82 |
| Volume | 3.16K |
| Open | 148.92 |
| Previous Close | 148.34 |
| Day's Range | 147.65 - 148.92 |
| 52-Week Range | 135.34 - 183.64 |
| Holdings | 25 |
| Expense Ratio | 0.35% |
About BBH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Asset Class Equity
Ticker Symbol BBH
Inception Date Dec 19, 2011
Provider Vaneck
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 72.31% of assets
| Name | Symbol | Weight |
|---|---|---|
| Amgen Inc. | AMGN | 16.11% |
| Gilead Sciences, Inc... | GILD | 13.48% |
| Vertex Pharmaceutica... | VRTX | 11.02% |
| Argenx Se | ARGX | 5.45% |
| Natera, Inc. | NTRA | 5.36% |
| Regeneron Pharmaceut... | REGN | 5.34% |
| Alnylam Pharmaceutic... | ALNY | 5.14% |
| Iqvia Holdings Inc. | IQV | 3.79% |
| Biogen Inc. | BIIB | 3.55% |
| Illumina, Inc. | ILMN | 3.07% |
Dividends Dividend Yield 0.79%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 23, 2024 | $1.2517 | Dec 24, 2024 |
| Dec 18, 2023 | $0.7127 | Dec 22, 2023 |
| Dec 19, 2022 | $0.7488 | Dec 23, 2022 |
| Dec 20, 2021 | $0.3972 | Dec 27, 2021 |
| Dec 21, 2020 | $0.6079 | Dec 28, 2020 |
